Department for Health, University of Bath, Bath, UK.
Royal National Hospital for Rheumatic Diseases, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.
Syst Rev. 2023 Jul 29;12(1):129. doi: 10.1186/s13643-023-02276-4.
Rheumatic and musculoskeletal diseases (RMDs) cause significant burden to the individual and society, requiring lifelong management and specialist healthcare resource use. Costing over 200 billion euros per year in Europe, RMDs are the most expensive of all diseases for European healthcare systems. The incidence and burden of RMDs are projected to rise with the ageing global population and increase in sedentary, obesogenic lifestyles. In parallel, there is a global crisis in the rheumatology workforce, whereby capacity to deliver specialist care is being exceeded by demand. Pervasive, scalable mobile health technologies, such as apps, are being developed to support the self-management of RMDs and reduce pressure on healthcare services. However, it is unknown whether these apps are informed by theory or their use supported by an appropriate evidence base. The purpose of this review is therefore to provide a comprehensive overview of the development strategies, interventional components and theoretical underpinnings of existing smartphone apps, designed to support the self-management of RMDs.
Searches will be conducted within PubMed, Scopus, Web of Science, Embase, MEDLINE and PsycINFO. Reference lists and citing articles of the included studies will be searched. Identified publications will be screened for eligibility by two independent reviewers. Any discrepancies between reviewers will be resolved by consensus, with input from a third reviewer if required. Data will be extracted on study designs, methods, populations, setting, utilised theoretical frameworks, intervention components, behaviour change techniques, methods to evaluate effectiveness and barriers/facilitators to intervention engagement. Exploratory outcomes include reported effectiveness, acceptability and usability. A systematic, narrative synthesis of evidence will be presented. If appropriate (depending on quality and pool of evidence identified), qualitative meta-summary techniques will be used to combine and summarise qualitative findings regarding barriers/facilitators to intervention engagement.
The results of this systematic literature review will provide insights for healthcare professionals, researchers, app designers and policy makers, to inform future development and implementation of smartphone apps to support self-management of RMDs. Evidence gaps for future research will be identified. Findings will be disseminated through a final manuscript/publication of results and via a conference abstract, patient organisations and social media.
PROSPERO CRD42022359704.
风湿和肌肉骨骼疾病（RMDs）给个人和社会带来了巨大的负担，需要终身管理和专科医疗资源的使用。在欧洲，RMDs 的年花费超过 2000 亿欧元，是欧洲所有疾病中最昂贵的。随着全球人口老龄化和久坐不动、肥胖症生活方式的增加，RMDs 的发病率和负担预计将会增加。与此同时，风湿病劳动力在全球范围内出现危机，提供专科护理的能力已经超过了需求。为了支持 RMDs 的自我管理并减轻医疗服务的压力，正在开发普遍存在且可扩展的移动健康技术，例如应用程序。然而，尚不清楚这些应用程序是否基于理论，或者它们的使用是否得到了适当的证据基础的支持。因此，本综述的目的是全面概述现有的智能手机应用程序的开发策略、干预组件和理论基础，旨在支持 RMDs 的自我管理。
将在 PubMed、Scopus、Web of Science、Embase、MEDLINE 和 PsycINFO 中进行搜索。将检索纳入研究的参考文献列表和引用文章。由两名独立审查员筛选确定的出版物是否符合入选标准。如果审查员之间存在分歧，则将通过共识解决，如有必要，将由第三名审查员介入。将提取有关研究设计、方法、人群、环境、使用的理论框架、干预组件、行为改变技术、评估有效性的方法以及干预参与的障碍/促进因素的数据。探索性结果包括报告的有效性、可接受性和可用性。将呈现证据的系统、叙述性综合。如果适当（取决于确定的质量和证据库），将使用定性元总结技术来组合和总结干预参与障碍/促进因素的定性发现。
这项系统文献综述的结果将为医疗保健专业人员、研究人员、应用程序设计师和政策制定者提供见解，以告知未来开发和实施支持 RMDs 自我管理的智能手机应用程序。将确定未来研究的证据差距。研究结果将通过最终手稿/结果出版物以及会议摘要、患者组织和社交媒体进行传播。
PROSPERO CRD42022359704。
